Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: August 2012
-
The Center for Business Intelligence (CBI) will be holding its 4th Life Sciences Congress on Paragraph IV Disputes on October 25-26, 2012 in Washington, DC. The conference will offer presentations on the following topics: • Through the looking glass — Fine-tune fundamentals of Hatch-Waxman and anticipate future developments in patent litigation;• The next big wave…
-
By Kevin E. Noonan — Earlier this month we asked for examples of instances where claims to isolated DNA interfered with basic research (see "The Proper Scope of DNA (or "Gene") Patent Claims"). We posited that the claim would be something like this one: An isolated (human) nucleic acid (or DNA molecule or gene (specified…
-
By Kevin E. Noonan — Long before DNA sequencing technology existed (indeed, long before Watson and Crick proposed that DNA was the genetic material and proposed a structural basis for its ability to be replicated), scientists were able to study genome structure using strictly genetic approaches. Genetic linkage maps, for example, date from the work…
-
By Kevin E. Noonan — "Genome projects" for a variety of species (comprising a complete sequence determination of a species' genomic DNA) has been underway for the past dozen or so years, in the wake of the completion of the Human Genome Project at the turn of the century. While such a sequence determination remains…
-
By Kevin E. Noonan — In a case otherwise of little interest to the biotech/pharma community, the Federal Circuit last month increased the burden on proving patentability created by prior art references for patent applicants and patentees. This was accomplished by defining a presumption of enablement not only for prior patents and published patent applications…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Bayer Intellectual Property GmbH et al. v. Warner Chilcott Company LLC et al.1:12-cv-01032; filed August 13, 2012 in the District Court of Delaware • Plaintiffs: Bayer Intellectual Property GmbH; Bayer Pharma AG• Defendants: Warner Chilcott…
-
August 21, 2012 – Mayo v. Prometheus: The Supreme Court's New Methodology for Analyzing Patent Eligibility (American Bar Association) – 1:00 – 2:30 pm (EDT) August 22, 2012 – The Final USPTO AIA Rules: What You Need to Know (American Intellectual Property Law Association) – 12:30 – 2:00 pm (Eastern) August 24, 2012 – The…
-
The ABA Journal has begun work on its 6th annual list of the 100 best legal blogs (or blawgs) and has announced that it is seeking the advice of its readers, via the ABAJournal.com website, on which blawgs and practice areas to include on this year's Blawg 100. Readers interested in nominating a particular blog…
-
American Conference Institute (ACI) will be holding its FDA Boot Camp Devices Edition conference on October 24-25, 2012 in Chicago, IL. ACI faculty will help attendees: • Master the basics of the application and approval processes, including 510(k) clearance and PMAs;• Navigate the complexities of device regulations;• Comprehend the structure of the FDA and the…
-
The American Intellectual Property Law Association (AIPLA) will be offering a webinar entitled "The Final USPTO AIA Rules: What You Need to Know" on August 22, 2012 from 12:30 – 2:00 pm (Eastern). Sally Medley, Administrative Patent Judge with the USPTO Board of Patent Trials and Appeals, and Janet Gongola, Patent Reform Coordinator for the…
Patent Docs 